Literature DB >> 26221303

ABCB1 polymorphism and susceptibility to acute lymphoblastic leukemia: a meta analysis.

Haiyan Zhang1, Zhen Zhang1, Guang Li2.   

Abstract

BACKGROUND: A large body of studies has investigated the potential role of ABCB1 polymorphism in ALL susceptibility. However, the results are conflicting. The aim of the present meta-analysis was to define the effect of ABCB1 polymorphism on ALL risk.
METHODS: We identified 8 eligible studies involving 1,308 cases and 1,427 controls through searching PubMed and Enbase databases. Odds ratios (ORs) with 95% confidence intervals (CIs) were used to access the strength of the association with both fixed effects and random effect models.
RESULTS: We found ABCB1 polymorphism was associated with an increased risk of ALL under the homozygote genotypes (TT vs. CC: OR, 1.29, 95% CI, 1.08-1.54), the recessive model (TT vs. CT + CC: OR, 1.47, 95% CI, 1.02-2.13) and the allele model (T vs. C: OR, 1.14, 95% CI, 1.04-1.25). Similar results were indicated in Asian populations (TT vs. CC: OR, 1.79, 95% CI, 1.32-2.43; TT vs. CT + CC: OR, 2.55, 95% CI, 1.47-4.43; T vs. C: OR, 1.38, 95% CI, 1.18-1.62), but not in Caucasian populations.
CONCLUSIONS: These findings indicate that ABCB1 polymorphism may play a critical role in the development of ALL in Asians.

Entities:  

Keywords:  ABCB1; ALL; polymorphism

Year:  2015        PMID: 26221303      PMCID: PMC4509248     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  32 in total

Review 1.  The physiological function of drug-transporting P-glycoproteins.

Authors:  A H Schinkel
Journal:  Semin Cancer Biol       Date:  1997-06       Impact factor: 15.707

2.  Meta-analysis in clinical trials.

Authors:  R DerSimonian; N Laird
Journal:  Control Clin Trials       Date:  1986-09

3.  Monoclonal antibodies against P-glycoprotein, an MDR1 gene product, inhibit interleukin-2 release from PHA-activated lymphocytes.

Authors:  G Raghu; S W Park; I B Roninson; E B Mechetner
Journal:  Exp Hematol       Date:  1996-08       Impact factor: 3.084

Review 4.  Genetic susceptibility to childhood acute lymphoblastic leukemia.

Authors:  D Sinnett; M Krajinovic; D Labuda
Journal:  Leuk Lymphoma       Date:  2000-08

5.  Expression and activity of P-glycoprotein, a multidrug efflux pump, in human hematopoietic stem cells.

Authors:  P M Chaudhary; I B Roninson
Journal:  Cell       Date:  1991-07-12       Impact factor: 41.582

Review 6.  Folate related gene polymorphisms and susceptibility to develop childhood acute lymphoblastic leukaemia.

Authors:  Ilan J N Koppen; Frederik J R Hermans; Gertjan J L Kaspers
Journal:  Br J Haematol       Date:  2009-09-22       Impact factor: 6.998

7.  [Relationship between genetic polymorphism of multidrug resistance 1 gene and the risk of childhood acute lymphocytic leukemia].

Authors:  Hui Lü; Zhi-Zhuo Du; Wei Wang; Wei Wang; Wen-li Zhao; Yi Wang; Shao-yan Hu; Yi-huan Chai
Journal:  Zhonghua Er Ke Za Zhi       Date:  2012-09

8.  MDR1 C3435T polymorphism in Mexican children with acute lymphoblastic leukemia and in healthy individuals.

Authors:  Evelia Leal-Ugarte; Melva Gutiérrez-Angulo; Nelly M Macías-Gómez; Valeria Peralta-Leal; Jorge Durán-González; María De La Luz Ayala-Madrigal; Miriam Partida-Pérez; Patricio Barros-Núñez; Dinorah Ruiz-Díaz; José M Moreno-Ortiz; Jorge Peregrina-Sandoval; Juan Pablo Meza-Espinoza
Journal:  Hum Biol       Date:  2008-08       Impact factor: 0.553

9.  Outcome in children with relapsed acute myeloid leukemia after initial treatment with the French Leucemie Aique Myeloide Enfant (LAME) 89/91 protocol of the French Society of Pediatric Hematology and Immunology.

Authors:  Nathalie Aladjidi; Anne Auvrignon; Thierry Leblanc; Yves Perel; Antoine Bénard; Pierre Bordigoni; Virginie Gandemer; Isabelle Thuret; Jean Hugues Dalle; Christophe Piguet; Brigitte Pautard; André Baruchel; Guy Leverger
Journal:  J Clin Oncol       Date:  2003-12-01       Impact factor: 44.544

10.  MDR1 gene variants, indoor insecticide exposure, and the risk of childhood acute lymphoblastic leukemia.

Authors:  Kevin Y Urayama; John K Wiencke; Patricia A Buffler; Anand P Chokkalingam; Catherine Metayer; Joseph L Wiemels
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2007-06       Impact factor: 4.254

View more
  1 in total

Review 1.  State of Art of Cancer Pharmacogenomics in Latin American Populations.

Authors:  Andrés López-Cortés; Santiago Guerrero; María Ana Redal; Angel Tito Alvarado; Luis Abel Quiñones
Journal:  Int J Mol Sci       Date:  2017-05-23       Impact factor: 5.923

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.